November 2009 Issue Table Of Contents

Editor’s Note

• I Hear You

Feature

• The Next Biopharma Business Model

Inside The Industry

• Biomarkers Increase R&D Success Rates, Preempt Failures, & Reduce Cost
• Molecular Screening: It’s Time To Stop Thinking Outside The Box With Counterfeit Drugs
• HPAPIs: Significant Challenges, A Wealth Of Opportunities
• PAT & QbD – Business Case Development
• Electronic Medical Device Reporting (eMDR) Best Practices
• Valuing A Life Sciences Company
• Tips For Enterprisewide ERP Deployment In Pharma
• Better Quantifying Clinical Trial Costs
• MDS Follows The Critical Path — And Sees Benefits
• How Technology Can Aid In The Relationship Between Society, Regulators, And The Life Sciences Industry
• When Will RPS Get Here, And What Will It Bring?

Industry Leader

• Can Single-Use Technology Be Automated?
• The Role Of The Clinical Lab In Detecting Adverse Events
• Managing Volatility, Risk, And Innovation In The Outsourced Pharma Services Sector